Jyoban Hospital of Tokiwa Foundation
- World rank, 2022–2025
- #22,360 of 28,054 · #37,491 all time
- Rank in Japan
- #709 of 1,070
- Research works
- 147 ▲ 240% vs 2013–17
- Citations
- 1.4k 9.8 per fractional work
- Top-10% rate
- 17.7% record average 16.5%
- Open access
- 72% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 14.1×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 14.1×
- Health Professions 3.9×
- Economics, Econometrics and Finance 3.7×
- Medicine 2.5×
- Nursing 1.8×
- Decision Sciences 1.4×
- Psychology 1.3×
- Environmental Science 1.0×
- Immunology and Microbiology 0.9×
- Biochemistry, Genetics and Molecular Biology 0.8×
- Social Sciences 0.7×
- Dentistry 0.5×
- Mathematics 0.4×
- Neuroscience 0.4×
- Business, Management and Accounting 0.2×
- Computer Science 0.1×
- Chemistry 0.1×
- Physics and Astronomy 0.1×
- Engineering 0.1×
- Agricultural and Biological Sciences 0.0×
Who are the top researchers at Jyoban Hospital of Tokiwa Foundation?
Ranked on the composite score, Hiroaki Shimmura, Kazutaka Nakamura and Hiroaki Saito lead among researchers whose main affiliation is Jyoban Hospital of Tokiwa Foundation.
- 1 Hiroaki Shimmura Japan · #631,345 worldwide 20 citations · 21 works
- 2 Kazutaka Nakamura Japan · #829,502 worldwide 12 citations · 22 works
- 3 Hiroaki Saito Japan · #881,395 worldwide 99 citations · 100 works
- 4 Tomohiro Kurokawa Japan · #894,769 worldwide 10 citations · 23 works
- 5 Akihiko Ozaki Japan · #1,102,516 worldwide 40 citations · 52 works
- 6 Toyoaki Sawano Japan · #1,351,769 worldwide 21 citations · 25 works
Which keywords describe research at Jyoban Hospital of Tokiwa Foundation?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Public Health, Pharmaceutical Industry, Clinical Trials, Ethical Considerations, Infectious Diseases, Immunotherapy, Molecular Characterization and Healthcare Workers.
- PD-1 and PD-L1
- Neoadjuvant Therapy
- Therapy
- Nephron-Sparing Surgery
- Genetic Mutations
- nuclear accident
- Fukushima Daiichi
- Drug Development Costs
- Chemotherapy
- Triage
- Research Outcome
- Medical Ethics
- Disaster Response
- Clinical Guidelines
- Quality of Life
- Healthcare Workers
- Treatment
- Immunotherapy
- Clinical Trials
- Epidemiology
- Public Health
- Pharmaceutical Industry
- Ethical Considerations
- Infectious Diseases
- Molecular Characterization
- Tumor Microenvironment
- Cancer
- Conflict of Interest
- Health Effects
- Pandemic
- Resource Allocation
- Risk Perception
- Prognostic Factors
- Generic Drugs
- Radionuclides
- Mortality
- Metastatic
- Renal Cell Carcinoma
- Communication
- Immune Checkpoint Blockade
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Public Health7▲ 6.8×19 topics
- Epidemiology6▲ 2.3×33 topics
- Pharmaceutical Industry6▲ 206×2 topics
- Clinical Trials4▲ 9.5×8 topics
- Ethical Considerations4▲ 17×7 topics
- Immunotherapy4▲ 7.6×8 topics
- Infectious Diseases4▲ 17×6 topics
- Treatment4▲ 4.5×13 topics
- Molecular Characterization4▲ 29×3 topics
- Healthcare Workers4▲ 20×3 topics
- Tumor Microenvironment3▲ 10×4 topics
- Quality of Life3▲ 3.1×14 topics
- Cancer3▲ 3.2×9 topics
- Clinical Guidelines3▲ 14×4 topics
- Conflict of Interest3▲ 449×1 topic
- Disaster Response3▲ 55×1 topic
- Health Effects3▲ 6.8×6 topics
- Medical Ethics3▲ 31×2 topics
- Pandemic3▲ 3.9×8 topics
- Research Outcome3▲ 449×1 topic
- Resource Allocation3▲ 24×2 topics
- Triage3▲ 98×1 topic
- Risk Perception3▲ 14×4 topics
- Chemotherapy3▲ 5.4×14 topics
- Prognostic Factors3▲ 8.8×6 topics
- Drug Development Costs3▲ 140×1 topic
- Generic Drugs3▲ 140×1 topic
- Fukushima Daiichi2▲ 229×1 topic
- Radionuclides2▲ 93×2 topics
- nuclear accident2▲ 229×1 topic
- Mortality2▲ 5.8×8 topics
- Genetic Mutations2▲ 7.3×4 topics
- Metastatic2▲ 48×2 topics
- Nephron-Sparing Surgery2▲ 87×1 topic
- Renal Cell Carcinoma2▲ 87×1 topic
- Therapy2▲ 15×2 topics
- Communication2▲ 9.1×3 topics
- Neoadjuvant Therapy2▲ 12×5 topics
- Immune Checkpoint Blockade2▲ 24×1 topic
- PD-1 and PD-L12▲ 24×1 topic
Which research topics does Jyoban Hospital of Tokiwa Foundation publish most on?
By volume in 2022–2025: Pharmaceutical industry and healthcare, Disaster Response and Management, Pharmaceutical Economics and Policy and Radioactive contamination and transfer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pharmaceutical industry and healthcare Pharmacology 3 works
- 2 Disaster Response and Management Emergency Medical Services 3 works
- 3 Pharmaceutical Economics and Policy Economics and Econometrics 3 works
- 4 Radioactive contamination and transfer Global and Planetary Change 2 works
- 5 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 2 works
- 6 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 7 Risk Perception and Management Sociology and Political Science 2 works
- 8 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 9 Bladder and Urothelial Cancer Treatments Surgery 1 works
- 10 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Jyoban Hospital of Tokiwa Foundation's research output changed?
Output in 2018–2022 was 240% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Iwaki
- Mitsubishi Chemical (Japan)
- IRYO Sosei University
- Japan Racing Association
- Iwaki Kyoritsu General Hospital
- Fukushima National College of Technology
- Higashi Nippon International University
- Fukushima Iwaki Agricultural High School
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.